Rion Co., Ltd. (JP:6823)
:6823
Want to see JP:6823 full AI Analyst Report?
Top Page
Rion Co., Ltd.
(6823)
Select Model
Select Model
Rating:83Outperform
Price Target:
¥4,252.00
▲(58.01% Upside)
Action:Reiterated
Date:05/02/26
The score is driven primarily by strong financial performance (steady growth, improving profitability, and a very low-debt balance sheet) and supportive valuation (low P/E with a moderate dividend). The main constraint is technical positioning: the uptrend is strong, but indicators are highly overbought, increasing short-term downside risk.
Positive Factors
Conservative balance sheet
Near-zero leverage and steadily compounding equity give Rion durable financial flexibility. This conservatism reduces refinancing and solvency risk, lets management fund capex, R&D, dividends or M&A internally, and supports resilience across 2–6 month industry cycles.
Negative Factors
Free cash flow volatility
Volatile FCF indicates swings in working capital or uneven investment timing, which reduces predictability of internal funding. That intermittency can constrain capital allocation, make budgeting harder, and raise execution risk for multi-month projects or steady shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Near-zero leverage and steadily compounding equity give Rion durable financial flexibility. This conservatism reduces refinancing and solvency risk, lets management fund capex, R&D, dividends or M&A internally, and supports resilience across 2–6 month industry cycles.
Read all positive factors
Rion Co., Ltd. (6823) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥43.53B
Dividend Yield2.93%
Average Volume (3M)26.46K
Price to Earnings (P/E)7.6
Beta (1Y)1.08
Revenue Growth2.24%
EPS Growth16.89%
CountryJP
Employees1,026
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)247.93
Shares Outstanding12,347,700
10 Day Avg. Volume21,140
30 Day Avg. Volume26,463
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)0.96
Price to Sales (P/S)1.17
P/FCF Ratio9.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)283.9
Revenue Forecast (FY)¥30.00B
Rion Co., Ltd. Business Overview & Revenue Model
Company Description
Rion Co., Ltd. manufactures, sells, and maintains hearing instruments, medical equipment, sound and vibration measuring instruments, particle counters, and related parts and equipment in Japan. The company's audiological equipment includes hearing...
How the Company Makes Money
Rion makes money primarily by selling hardware products across two main domains: (1) measurement instruments and related systems (e.g., sound level meters, noise and vibration measurement equipment, data acquisition/analysis solutions) to corporat...
Rion Co., Ltd. Financial Statement Overview
Summary
Income Statement
83
Very Positive
Balance Sheet
92
Very Positive
Cash Flow
78
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.15B | 28.50B | 27.88B | 25.73B | 23.87B | 22.64B |
| Gross Profit | 13.97B | 13.98B | 15.35B | 14.33B | 12.69B | 12.22B |
| EBITDA | 5.46B | 5.77B | 5.28B | 4.38B | 3.59B | 3.82B |
| Net Income | 3.05B | 3.35B | 2.86B | 2.65B | 1.80B | 2.23B |
Balance Sheet | ||||||
| Total Assets | 38.98B | 41.78B | 39.13B | 37.40B | 34.81B | 33.42B |
| Cash, Cash Equivalents and Short-Term Investments | 6.16B | 8.56B | 6.01B | 5.03B | 5.37B | 7.72B |
| Total Debt | 1.73B | 0.00 | 11.73M | 21.88M | 28.46M | 40.07M |
| Total Liabilities | 7.36B | 6.98B | 7.70B | 8.19B | 8.20B | 8.14B |
| Stockholders Equity | 31.62B | 34.80B | 31.44B | 29.21B | 26.61B | 25.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.56B | 2.14B | 725.98M | 473.30M | 2.31B |
| Operating Cash Flow | 0.00 | 4.17B | 3.44B | 2.86B | 1.78B | 2.84B |
| Investing Cash Flow | 0.00 | -753.08M | -1.69B | -2.65B | -3.25B | -951.93M |
| Financing Cash Flow | 0.00 | -954.63M | -748.84M | -565.55M | -577.32M | -541.83M |
Rion Co., Ltd. Technical Analysis
Positive
2691.00
Price Trends
3075.25
Positive
2911.72
Positive
2729.71
Positive
Market Momentum
145.77
Positive
64.72
Neutral
29.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6823, the sentiment is Positive. The current price of 2691 is below the 20-day moving average (MA) of 3424.00, below the 50-day MA of 3075.25, and below the 200-day MA of 2729.71, indicating a bullish trend. The MACD of 145.77 indicates Positive momentum. The RSI at 64.72 is Neutral, neither overbought nor oversold. The STOCH value of 29.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6823.
Rion Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥43.53B | 7.62 | ― | 2.93% | 2.24% | 16.89% | |
78 Outperform | ¥17.91B | 15.06 | ― | 3.02% | 13.43% | 7.06% | |
61 Neutral | ¥249.58B | 16.30 | ― | 1.92% | 4.29% | 3.92% | |
55 Neutral | ¥96.14B | 27.16 | ― | 2.31% | 3.35% | 74.40% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥18.67B | 53.77 | ― | 3.12% | -4.77% | ― | |
47 Neutral | ¥130.02B | 279.88 | 2.42% | 3.73% | 0.78% | -95.37% |
* Healthcare Sector Average
JP:6823
Rion Co., Ltd.
3,530.00
1,192.91
51.04%
JP:6523
PHC Holdings Corp.
1,026.00
107.25
11.67%
JP:4549
Eiken Chemical Co., Ltd.
2,916.00
970.80
49.91%
JP:6678
Techno Medica Co., Ltd.
2,101.00
367.69
21.21%
JP:6849
Nihon Kohden Corporation
1,495.00
-133.71
-8.21%
JP:7600
Japan Medical Dynamic Marketing, Inc.
709.00
190.68
36.79%
Rion Co., Ltd. Corporate Events
Rion Lifts Profit, Cash Position and Dividends, Forecasts Further Growth for FY2027
Apr 28, 2026
Rion Co., Ltd. reported consolidated net sales of ¥28.5 billion for the year ended March 31, 2026, up 2.2% year on year, with operating profit rising 8.1% to ¥4.36 billion and profit attributable to owners of parent jumping 17.0% to ...
Rion Reshapes Executive and Management Ranks Across Group Operations
Feb 16, 2026
Rion Co., Ltd. has announced a series of senior personnel changes effective April 1, 2026, including new roles for several executive officers overseeing corporate planning, research and development, personnel and general affairs, and production. T...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.